|
|
Article: Ambien(R) (Zolpidem Tartrate) C(IV) Shown Safe and Effective With Longer-Term Use, Say Study Investigators at APA.
- Article from:
- PR Newswire
- Article date:
- May 6, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
12-Week Trial Shows No Tolerance or Dose Escalation
Results of a 12-week, placebo-controlled clinical trial with Ambien(R) (zolpidem tartrate) C(IV), the leading prescription sleep aid in the U.S.,(1) demonstrated that the product safely and effectively treated insomnia intermittently with no evidence of tolerance or dose escalation -- complications often seen with extended use of older-generation sleep medications. The study, presented today at the 2004 American Psychiatric Association Annual Meeting, evaluated up to 5 nights of dosing per week, as needed, and underscored that the improvements in sleep provided by Ambien did not diminish over time and that ...